Medical News

RSS
FDA approves Medacta’s two new kinematic alignment options for knee replacement surgery

FDA approves Medacta’s two new kinematic alignment options for knee replacement surgery

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

Phase 2 study of ziresovir for treating hospitalized RSV infected infants achieves significant progress

Phase 2 study of ziresovir for treating hospitalized RSV infected infants achieves significant progress

Phase 2 STEMTRA trial using SB623 cells for treating traumatic brain injury meets primary endpoint

Phase 2 STEMTRA trial using SB623 cells for treating traumatic brain injury meets primary endpoint

Canadian medics adopt pioneering learning technology to ensure safer prescribing techniques

Canadian medics adopt pioneering learning technology to ensure safer prescribing techniques

Observing functional changes of cells in blood vessels may help detect early signs of atherosclerosis

Observing functional changes of cells in blood vessels may help detect early signs of atherosclerosis

Policymakers should introduce more targeted early interventions to tackle cancer

Policymakers should introduce more targeted early interventions to tackle cancer

Researchers developing novel face mask that offers clear view of  wearer's facial expressions

Researchers developing novel face mask that offers clear view of wearer's facial expressions

PAREXEL launches new China Advisory Service to help global biopharmaceutical companies navigate market opportunity within China

PAREXEL launches new China Advisory Service to help global biopharmaceutical companies navigate market opportunity within China

Retinal sheet transplants restore vision in blind rats

Retinal sheet transplants restore vision in blind rats

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Researchers uncover link between RNA abnormalities and multiple myeloma progression

Researchers uncover link between RNA abnormalities and multiple myeloma progression

Presence of rare mutations indicates increased risk from interval breast cancers

Presence of rare mutations indicates increased risk from interval breast cancers

New project aims to estimate scientific basis of health risks posed by substance mixtures

New project aims to estimate scientific basis of health risks posed by substance mixtures

New study to evaluate human immune system's response to influenza

New study to evaluate human immune system's response to influenza

Researchers cross-reference historical divergence of Aedes aegypti populations

Researchers cross-reference historical divergence of Aedes aegypti populations

Childlessness influences Chinese adults' end-of-life care preferences

Childlessness influences Chinese adults' end-of-life care preferences

High blood pressure caused by specific signaling from the brain promotes heart disease

High blood pressure caused by specific signaling from the brain promotes heart disease

Repair defect in neurons hints at possible therapy for preventing ALS

Repair defect in neurons hints at possible therapy for preventing ALS

IU Philanthropic Venture Fund commits to invest $500,000 to NERx Biosciences company

IU Philanthropic Venture Fund commits to invest $500,000 to NERx Biosciences company

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.